© Khunaspix Dreamstime.

CNBC reports:

– Dr. Albert Bourla, chairman and CEO of Pfizer, hailed the trial results as a “great day for science and humanity.”

– Pfizer and BioNTech said the case split between vaccinated individuals and those who received a placebo indicated a vaccine efficacy rate of above 90% at seven days after the second dose.

– It means that protection from Covid-19 is achieved 28 days after the initial vaccination, which consists of a two-dose schedule.

U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial.

It comes as drugmakers and research centers around the world scramble to deliver a safe and effective vaccine in an attempt to bring an end to the coronavirus pandemic that has claimed over 1.25 million lives worldwide.

Scientists are hoping for a coronavirus vaccine that is at least 75% effective, while White House coronavirus advisor Dr. Anthony Fauci has previously said one that is 50% or 60% effective would be acceptable.

To read the full post, please click here.


– Pre-market reaction: “Stock futures surge, with Dow futures up 1400 points, after Pfizer vaccine trial. Pfizer CEO: ‘Today is a great day for science and humanity.’

– More here: “S&P futures, global stocks soar to all time high, Russell limit up on Covid vaccine news“. 

– Early pre-market (pre-vaccine) trade: “Risk assets jump as traders put money to work“.

– Wall Street Breakfast: “Post-election rally continues“.

– Brent up a lot. Gold under pressure.

Rates soar closer to 1%…

VIX down to 23.50 (-14.7%) @ 1.48pm GMT.

Comment on this article

You must be logged in to post a comment.